Complement 1 | Search

Trials

200 participants · First posted Mar 28, 2012

Completed

NCT06495151

Endometriosis and Complement System

58 participants · First posted Jul 10, 2024

Not yet recruiting

NCT07495722

Safely Quenching Complement in Stroke Survivors

20 participants · First posted Mar 27, 2026

Drugs

View all 7285 →

Soluble complement receptor 1(Celldex Therapeutics)

Biotech

Approved

Human C1-esterase inhibitor(Berinert, Cinryze, Haegarda)

Conditions: Acute attacks of hereditary angioedema, Acute attack of hereditary angioedema of the Abdomen +2 more

Bifunctional complement inhibitor

Organizations

View all 1383 →

NHI-1

United States

Xi'an No.1 Hospital

China

ALPHA-1 FOUNDATION, INC.

United States

News

View all 15731 →

last year

Complement 1 Raises $16M to Scale AI-Powered Cancer Lifestyle Platform with 90% Patient Adherence

last year

ImmunAbs Receives FDA Clearance for Phase 2 Trial of IM-101 Complement Inhibitor in Myasthenia Gravis

last year

Trials

Erythrocyte Complement Receptor 1 and Alzheimer Disease

Endometriosis and Complement System

Safely Quenching Complement in Stroke Survivors

Drugs

Soluble complement receptor 1(Celldex Therapeutics)

Human C1-esterase inhibitor(Berinert, Cinryze, Haegarda)

Bifunctional complement inhibitor

Organizations

NHI-1

Xi'an No.1 Hospital

ALPHA-1 FOUNDATION, INC.

News

Complement 1 Raises $16M to Scale AI-Powered Cancer Lifestyle Platform with 90% Patient Adherence

ImmunAbs Receives FDA Clearance for Phase 2 Trial of IM-101 Complement Inhibitor in Myasthenia Gravis

MSD Discontinues Development of TIGIT and LAG-3 Cancer Immunotherapy Programs